Gp Act Iii Acquisition Stock Year To Date Return
| GPAT Stock | 10.14 0.01 0.1% |
GP Act III Acquisition fundamentals help investors to digest information that contributes to GP Act's financial success or failures. It also enables traders to predict the movement of GPAT Stock. The fundamental analysis module provides a way to measure GP Act's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GP Act stock.
GPAT |
GP Act III Acquisition Company Year To Date Return Analysis
GP Act's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
GPAT Year To Date Return Driver Correlations
Understanding the fundamental principles of building solid financial models for GP Act is extremely important. It helps to project a fair market value of GPAT Stock properly, considering its historical fundamentals such as Year To Date Return. Since GP Act's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GP Act's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GP Act's interrelated accounts and indicators.
Click cells to compare fundamentals
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
| Competition |
GPAT Return On Tangible Assets
Return On Tangible Assets |
|
According to the company's disclosures, GP Act III Acquisition has a Year To Date Return of 0.0%. This indicator is about the same for the Financial Services average (which is currently at 0.0) sector and about the same as Financials (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
GPAT Year To Date Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in year to date return category among its peers.
GPAT Fundamentals
| Current Valuation | 364.29 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 40.32 % | ||||
| Number Of Shares Shorted | 30.81 K | ||||
| Price To Book | 1.30 X | ||||
| EBITDA | (14.04 K) | ||||
| Net Income | (14.04 K) | ||||
| Total Debt | 628.18 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (10.97 K) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | 0.15 X | ||||
| Market Capitalization | 364.41 M | ||||
| Total Asset | 530.24 K | ||||
| Retained Earnings | (122.94 K) | ||||
| Working Capital | (624.87 K) | ||||
| Net Asset | 530.24 K |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.